VanishPoint infringement verdict


Intravenous products: Retractable Technologies, Inc. (AMEX: RVP), a leading maker of safety needle devices, announced today that a Marshall, Texas, jury returned a verdict yesterday finding that all three patents asserted by Retractable Technologies, Inc. (“the “Company”) against Becton Dickinson and Company (“BD”) are valid and infringed. The jury also awarded damages to the Company in the amount of $5 million. The verdict, which can be appealed by either party, is directed against BDs infringing Integra® syringes.

Click here for the full story.


Comments are closed.